Shedding of Viable SARS-CoV-2 after Immunosuppressive Therapy for Cancer

N Engl J Med. 2020 Dec 24;383(26):2586-2588. doi: 10.1056/NEJMc2031670. Epub 2020 Dec 1.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • COVID-19 / complications
  • COVID-19 / virology*
  • Female
  • Hematopoietic Stem Cell Transplantation
  • Humans
  • Immunosuppression Therapy*
  • Male
  • Middle Aged
  • Neoplasms / complications
  • Neoplasms / therapy*
  • Virus Shedding*